- Home
- HUIZ vs MIRA Comparison
HUIZ vs MIRA Comparison
Compare HUIZ & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- MIRA
- Stock Information
- Founded
- HUIZ 2006
- MIRA 2020
- Country
- HUIZ China
- MIRA United States
- Employees
- HUIZ N/A
- MIRA N/A
- Industry
- HUIZ Specialty Insurers
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- MIRA Health Care
- Exchange
- HUIZ Nasdaq
- MIRA Nasdaq
- Market Cap
- HUIZ 25.3M
- MIRA 26.1M
- IPO Year
- HUIZ 2020
- MIRA 2023
- Fundamental
- Price
- HUIZ $2.59
- MIRA $1.40
- Analyst Decision
- HUIZ Hold
- MIRA Strong Buy
- Analyst Count
- HUIZ 1
- MIRA 1
- Target Price
- HUIZ $2.30
- MIRA $17.00
- AVG Volume (30 Days)
- HUIZ 32.3K
- MIRA 196.3K
- Earning Date
- HUIZ 09-12-2025
- MIRA 08-14-2025
- Dividend Yield
- HUIZ N/A
- MIRA N/A
- EPS Growth
- HUIZ N/A
- MIRA N/A
- EPS
- HUIZ N/A
- MIRA N/A
- Revenue
- HUIZ $168,454,627.00
- MIRA N/A
- Revenue This Year
- HUIZ $11.94
- MIRA N/A
- Revenue Next Year
- HUIZ $8.15
- MIRA N/A
- P/E Ratio
- HUIZ N/A
- MIRA N/A
- Revenue Growth
- HUIZ 1.28
- MIRA N/A
- 52 Week Low
- HUIZ $1.50
- MIRA $0.73
- 52 Week High
- HUIZ $10.58
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- HUIZ 57.05
- MIRA 45.09
- Support Level
- HUIZ $2.25
- MIRA $1.37
- Resistance Level
- HUIZ $2.60
- MIRA $1.46
- Average True Range (ATR)
- HUIZ 0.19
- MIRA 0.06
- MACD
- HUIZ 0.01
- MIRA -0.01
- Stochastic Oscillator
- HUIZ 84.23
- MIRA 23.81
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.